Expectant, management of severe preterm preeclampsia: Role of fetal growth restriction on outcomes

被引:0
|
作者
Malberti, Silvia [1 ]
Incerti, Maddalena [1 ]
Locatelli, Anna [1 ]
Consonni, Sara [1 ]
Greco, Massimilano [1 ]
Ghidini, Alessandro [1 ]
机构
[1] Univ Milano Bicoca, Dept Obstet & Gynecol, Monza, Italy
关键词
D O I
10.1016/j.ajog.2007.10.766
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
737
引用
收藏
页码:S209 / S209
页数:1
相关论文
共 50 条
  • [31] Umbilical Artery Doppler and Adverse Outcomes in Severe Preeclampsia Without Fetal Growth Restriction: A Retrospective Cohort Study
    Core, Daniel
    Zoorob, Dani
    Maxwell, Rose
    Maas, Madison Catalanotto
    Richardson, Elizabeth Hixson
    Fucinari, David
    Menefee, Christopher
    Landry, Layne
    Barrilleaux, Perry
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [32] Amount of Proteinuria and Duration of Expectant Management in Severe Preeclampsia
    Cozzi, Gabriella D.
    Battarbee, Ashley N.
    Sanjanwala, Aalok R.
    Casey, Brian M.
    Subramaniam, Akila
    AMERICAN JOURNAL OF PERINATOLOGY, 2024, 41 (06) : 790 - 797
  • [33] PLACENTAL PATHOLOGIC FEATURES OF FETAL GROWTH RESTRICTION AND PREECLAMPSIA IN PRETERM: ARE PLACENTAL LESIONS DIFFERENT?
    Chang, Kylie Hae-Jin
    Sung, Ji-Hee
    Choi, Suk-Joo
    Oh, Soo-Young
    Kim, Jung-Sun
    Roh, Cheong-Rae
    Kim, Jong-Hwa
    PLACENTA, 2015, 36 (09) : A54 - A55
  • [34] Preeclampsia, Fetal Growth Restriction, and 24-Month Neurodevelopment in Very Preterm Infants
    Check, Jennifer
    Shuster, Coral
    Hofheimer, Julie
    Camerota, Marie
    Dansereau, Lynne M.
    Smith, Lynne M.
    Carter, Brian S.
    DellaGrotta, Sheri A.
    Helderman, Jennifer
    Kilbride, Howard
    Loncar, Cynthia M.
    McGowan, Elisabeth
    Neal, Charles R.
    O'Shea, T. Michael
    Pastyrnak, Steven L.
    Sheinkopf, Stephen J.
    Lester, Barry M.
    JAMA NETWORK OPEN, 2024, 7 (07) : e2420382
  • [35] Expectant management of severe preeclampsia remote from term
    Friedman, SA
    Schiff, E
    Lubarsky, SL
    Sibai, BM
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1999, 42 (03): : 470 - 478
  • [36] Removing fetal growth restriction from the diagnostic criteria for severe preeclampsia: is it justified?
    Carter, Ebony
    Conner, Shayna
    Cahill, Alison
    Rampersad, Roxane
    Macones, George
    Tuuli, Methodius
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 212 (01) : S357 - S357
  • [37] Circulating Cell-Derived Microparticles in Severe Preeclampsia and in Fetal Growth Restriction
    Alijotas-Reig, Jaume
    Palacio-Garcia, Carles
    Farran-Codina, Immaculada
    Ruiz-Romance, Mar
    Llurba, Elisa
    Vilardell-Tarres, Miquel
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2012, 67 (02) : 140 - 151
  • [38] Characterization of fetal monocytes in preeclampsia and fetal growth restriction
    Alahakoon, Thushari, I
    Medbury, Heather
    Williams, Helen
    Fewings, Nicole
    Wang, Xin M.
    Lee, Vincent W.
    JOURNAL OF PERINATAL MEDICINE, 2019, 47 (04) : 434 - 438
  • [39] Type II and III Selective Fetal Growth Restriction: Perinatal Outcomes of Expectant Management and Laser Ablation of Placental Vessels
    Miyadahira, Mariana Yumi
    Brizot, Maria de Lourdes
    Burlacchini de Carvalho, Mario Henrique
    Biancolin, Sckarlet Ernandes
    Alam Machado, Rita de Cassia
    Jornada Krebs, Vera Lucia
    Vieira Francisco, Rossana Pulcineli
    Andrioli Peralta, Cleisson Fabio
    CLINICS, 2018, 73
  • [40] Diagnosis and management of fetal growth restriction: the role of fetal therapy
    Hui, Lisa
    Challis, Daniel
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2008, 22 (01) : 139 - 158